Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment

NCT00786773 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00786773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00786773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 31, 2008
Completion date
June 30, 2009
Enrollment
2,091 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease